Integrated marketing, communications and media agency hyper-focused on science.
Location: United States, District of Columbia, Washington
Employees: 201-500
Phone: +1 202-955-6222
Founded date: 1996
Investors 1
| Date | Name | Website |
| 20.02.2023 | Knox Lane | knoxlane.c... |
Mentions in press and media 9
| Date | Title | Description | Source |
| 12.03.2024 | NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Cl... | -- TANDEM is designed to evaluate obicetrapib and ezetimibe fixed-dose combination (“FDC”) as an adj... | forbion.co... |
| 21.11.2023 | Spectrum Science Buys CrowdPharm and Hot Iron Health | Spectrum Science, a Washington, DC-based healthcare and scientific marketing, communications and med... | finsmes.co... |
| 12.10.2023 | Emulate Earns Frost & Sullivan's 2023 Technology Innovat... | Cutting-edge Organ-on-a-Chip Technology Enhances R&D Productivity and Improves Patient Safety SA... | en.prnasia... |
| 27.02.2023 | Money Moves: Sublime raises $9.8M to build out email securit... | Money Moves is a column where we chart the funding raises of tech companies across the region. Have ... | technical.... |
| 08.02.2023 | Spectrum Science Receives Investment from Knox Lane | Spectrum Science, a Washington, DC-based integrated marketing, communications and media firm focused... | finsmes.co... |
| 09.12.2021 | Avidity Biosciences Highlights FSHD Program at Virtual Inves... | LA JOLLA, Calif., Dec. 9, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmac... | marketscre... |
| 04.11.2021 | Avidity Announces First Person Dosed with an Antibody Oligon... | LA JOLLA, Calif., Nov. 4, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmac... | marketscre... |
| 18.10.2021 | Avidity Biosciences : FDA Grants Fast Track Designation to A... | LA JOLLA, Calif., Oct. 18, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharma... | marketscre... |
| 25.08.2021 | Avidity Biosciences : Announces Changes to its Board of Dire... | LA JOLLA, Calif., Aug. 25, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA) a biopharmac... | marketscre... |